Canadian Institutes of Health Research
570,556 snapshots · latest May 3, 2026
Homepage:https://cihr-irsc.gc.ca/
Archive explorer
Browse & search snapshots
Important note
Browse and search historical snapshots. This is an archive — not current guidance or medical advice. Archived content may be incomplete, outdated, or superseded. For up-to-date recommendations, always consult the official source website.
For background on coverage and capture methods, see Methods & coverage.
Browse archived sites
Health Canada
386,223 snapshots · latest Apr 14, 2026
Public Health Agency of Canada
243,880 snapshots · latest Apr 28, 2026
Cannabis for medical purposes under the Cannabis Act: information and improvements On this page Access to cannabis for medical purposes For those accessing cannabis for medical purposes from a federally licensed seller For those registered with Health Canada to produce their own…
Counterfeit prescription drugs Learn about counterfeit prescription drugs, their risks to youth and how we try to prevent them. On this page About counterfeit prescription drugs Risks to youth Preventing counterfeit prescription drugs About counterfeit prescription drugs…
Get help with substance use On this page About Canada-wide services Provincial and territorial health and support services Programs for Indigenous peoples Substance use and chronic pain Mental health support About This page has resources and information for people who need help…
Canadian Student Alcohol and Drugs Survey Data on alcohol and drug use by youth in Canada. Explore trends in youth substance use over time, by province, and more with our interactive tool . Reports Summaries of results from previous survey cycles. 2023-2024 report 2021-2022…
Subsection 56(1) class exemption for practitioners, agents, pharmacists, persons in charge of a hospital, hospital employees, and licensed dealers to conduct activities with psilocybin and MDMA in relation to a special access program authorization This class exemption will be…
Application form for an exemption to use a controlled substance for scientific purposes To apply, you should be the Principal Investigator (PI) or person responsible for the project and should have a minimum of a bachelor’s degree in science (B.Sc.). If you are a practitioner,…
Controlled substance licence restrictions: Licences for controlled substances Licences Sale of controlled substances Advertising Compliance and enforcement Contact us This page is for holders of a controlled substances licence (dealer's licence). You should be familiar with the…
Notice to Stakeholders – Clarification of Requirements under the Food and Drug Regulations and the Controlled Drugs and Substances Act When Conducting Clinical Research with Psilocybin January 11, 2022 Our file number: 21-121678-792 Health Canada is issuing this notice to…
Guidance Document For Clinical Trial Sponsors: Clinical Trial Applications (PDF Version - 190 K) This guidance is being consulted on as part of the proposed clinical trial regulation modernization. To participate, please see Consultation: Modernizing the framework for clinical…
Good manufacturing practices guide for drug products (GUI-0001) Download the alternative format (PDF format, 2.4 MB, 159 pages) Organization: Health Canada Date published: July 2020 For industry information about good manufacturing practices and COVID-19, visit our Good…
Early release: coverage and features are still expanding.
